Some attorneys general are vowing to keep fighting the chapter 11 reorganization plan of Purdue Pharma LP and a $4.5 billion settlement with the family that owns the maker of OxyContin, which could force an influential federal appeals court to consider the scope of bankruptcy judges’ power to end lawsuits over defective or dangerous products.
Attorneys general for Washington state and Connecticut as well as the attorney general for Washington, D.C. said they would appeal Wednesday’s decision by Judge Robert Drain of the U.S….
